Header

UZH-Logo

Maintenance Infos

SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy


Gerlach, Magdalena M; Stelling-Germani, Anna; Wu, Cheuk Ting; Newrzela, Sebastian; Döring, Claudia; Vela, Visar; Müller, Anne; Hartmann, Sylvia; Tzankov, Alexandar (2020). SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy. Haematologica, 106(2):619-621.

Statistics

Citations

Dimensions.ai Metrics

Altmetrics

Downloads

6 downloads since deposited on 23 Nov 2020
6 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > Institute of Molecular Cancer Research
07 Faculty of Science > Institute of Molecular Cancer Research
Dewey Decimal Classification:570 Life sciences; biology
610 Medicine & health
Language:English
Date:16 April 2020
Deposited On:23 Nov 2020 16:08
Last Modified:10 Feb 2021 06:08
Publisher:Ferrata Storti Foundation
ISSN:0390-6078
OA Status:Gold
Free access at:PubMed ID. An embargo period may apply.
Publisher DOI:https://doi.org/10.3324/haematol.2020.249276
PubMed ID:32299904

Download

Gold Open Access

Download PDF  'SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy'.
Preview
Content: Accepted Version
Filetype: PDF
Size: 1MB
View at publisher